Difficulty of Funding Novel Ideas

 

Decades of cancer research has focused on killing cancer cells, which has proved to be nearly impossible with late stage or metastatic cancer, which kills 90% of cancer patients.  However, we have discovered that you don't have to kill metastatic cancer cells; metastatic cancer cells can be changed to normal healthy cells by treatment with the non-toxic molecule, methyl sulfone.  

This is a new paradigm for cancer treatment.  

Despite the fact that in 10 years of research we have never gotten a negative result, conventional funding areas and pharmaceutical companies have not been willing to help us move our research forward.  One reason, despite our four publications on methyl sulfone and our consistently strong data, our research is considered to be too risky.  

We are constantly being told to "do one more thing".  We feel like Dorothy from the Wizard of Oz.  The Wizard keeps telling Dorothy to do one more thing, like bring him the broom of the Wicked Witch of the West, and he will help Dorothy get home.

So my twin, Jane, and I have been using our retirement funds to support this research.  But we can't keep doing this.

As salt in the wound, one pharma company, where I gave a seminar on our research, told us that the science is brilliant, but methyl sulfone is too cheap for robust commercialization - it will not produce the $500 million that pharma companies have come to expect from sale of a single product.

As you can see, doing this research has been the best time in my life, but it has also been costly and frustrating.  Any help, donations and/or telling others about this research, will be gratefully appreciated.  

Thank you and be well, Joan.